Ling Yin
South China Agricultural University(CN)University of Science and Technology of China(CN)The University of Texas MD Anderson Cancer Center(US)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Lishui University(CN)University of Florida(US)Jiangxi Science and Technology Normal University(CN)Poultry Research Institute(CN)Fourth People’s Hospital of Jinan(CN)Jining University(CN)Xiyuan Hospital(CN)China Academy of Chinese Medical Sciences(CN)First Affiliated Hospital of Bengbu Medical College(CN)The University of Texas Southwestern Medical Center(US)
Publications by Year
Research Areas
Histone Deacetylase Inhibitors Research, Synthesis and biological activity, Advanced Nanomaterials in Catalysis, DNA Repair Mechanisms, Advanced biosensing and bioanalysis techniques
Most-Cited Works
- → Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response(2022)269 cited
- → Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for the Treatment of Cancer(2010)261 cited
- → Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling(2012)239 cited
- → CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity(2010)212 cited
- → Notch signaling: Emerging molecular targets for cancer therapy(2010)182 cited
- → Mild cognitive impairment among rural‐dwelling older adults in China: A community‐based study